Class information for:
Level 1: NANOART//PHARMACEUT NANOMAT SCI//PHARMACOL EXPT NEUROSCI

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
26650 249 53.8 82%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
12 4 POLYMER SCIENCE//MATERIALS SCIENCE, PAPER & WOOD//CHEMISTRY, PHYSICAL 1084170
41 3       INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//PHARMACOLOGY & PHARMACY 99449
147 2             SOLID LIPID NANOPARTICLES//POLYMERIC MICELLES//LIPOSOMES 23275
26650 1                   NANOART//PHARMACEUT NANOMAT SCI//PHARMACOL EXPT NEUROSCI 249

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 NANOART authKW 858423 3% 100% 7
2 PHARMACEUT NANOMAT SCI address 339589 2% 46% 6
3 PHARMACOL EXPT NEUROSCI address 333238 17% 6% 42
4 NANOFORMULATED ANTIRETROVIRAL THERAPY authKW 275920 1% 75% 3
5 PEDIATRIC HIV AIDS PHARMACOTHERAPY authKW 275920 1% 75% 3
6 GRP BIOMAT NANOTECHNOL IMPROVED MED BIONIMED address 275908 4% 25% 9
7 ANTIRETROVIRAL DRUG TARGETING authKW 245264 1% 100% 2
8 LIPID ASSOCIATED DRUG authKW 245264 1% 100% 2
9 LONG ACTING NANOFORMULATED ANTIRETROVIRAL THERAPY authKW 245264 1% 100% 2
10 LYMPHATIC DRUG INSUFFICIENCY authKW 245264 1% 100% 2

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Pharmacology & Pharmacy 1545 46% 0% 115
2 Nanoscience & Nanotechnology 1099 23% 0% 57
3 Virology 335 9% 0% 23
4 Materials Science, Biomaterials 266 6% 0% 14
5 Infectious Diseases 248 10% 0% 25
6 Medicine, Research & Experimental 133 10% 0% 24
7 Biotechnology & Applied Microbiology 116 10% 0% 26
8 Chemistry, Multidisciplinary 55 12% 0% 31
9 Immunology 54 9% 0% 22
10 Chemistry, Medicinal 23 4% 0% 9

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PHARMACEUT NANOMAT SCI 339589 2% 46% 6
2 PHARMACOL EXPT NEUROSCI 333238 17% 6% 42
3 GRP BIOMAT NANOTECHNOL IMPROVED MED BIONIMED 275908 4% 25% 9
4 PERSONALIZED NANOMED IMMUNOL 220735 1% 60% 3
5 DRUG DELIVERY NANOMED 160634 5% 10% 13
6 ADMET PK BAC 122632 0% 100% 1
7 AICA S 122632 0% 100% 1
8 AU PK 122632 0% 100% 1
9 COUNCIL SCI IND MAT SCI MFG 122632 0% 100% 1
10 DRUG DELIVERY NANMED 122632 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 NANOMEDICINE 36339 8% 2% 19
2 NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE 6111 3% 1% 8
3 INTERNATIONAL JOURNAL OF NANOMEDICINE 4619 4% 0% 11
4 EXPERT OPINION ON DRUG DELIVERY 4114 2% 1% 6
5 DRUG DELIVERY AND TRANSLATIONAL RESEARCH 3698 1% 1% 3
6 JOURNAL OF DRUG TARGETING 2831 2% 0% 6
7 CURRENT DRUG DELIVERY 2368 1% 1% 3
8 ADVANCED DRUG DELIVERY REVIEWS 2239 3% 0% 7
9 JOURNAL OF NEUROIMMUNE PHARMACOLOGY 1783 1% 0% 3
10 DRUG DELIVERY 1506 2% 0% 4

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 NANOART 858423 3% 100% 7 Search NANOART Search NANOART
2 NANOFORMULATED ANTIRETROVIRAL THERAPY 275920 1% 75% 3 Search NANOFORMULATED+ANTIRETROVIRAL+THERAPY Search NANOFORMULATED+ANTIRETROVIRAL+THERAPY
3 PEDIATRIC HIV AIDS PHARMACOTHERAPY 275920 1% 75% 3 Search PEDIATRIC+HIV+AIDS+PHARMACOTHERAPY Search PEDIATRIC+HIV+AIDS+PHARMACOTHERAPY
4 ANTIRETROVIRAL DRUG TARGETING 245264 1% 100% 2 Search ANTIRETROVIRAL+DRUG+TARGETING Search ANTIRETROVIRAL+DRUG+TARGETING
5 LIPID ASSOCIATED DRUG 245264 1% 100% 2 Search LIPID+ASSOCIATED+DRUG Search LIPID+ASSOCIATED+DRUG
6 LONG ACTING NANOFORMULATED ANTIRETROVIRAL THERAPY 245264 1% 100% 2 Search LONG+ACTING+NANOFORMULATED+ANTIRETROVIRAL+THERAPY Search LONG+ACTING+NANOFORMULATED+ANTIRETROVIRAL+THERAPY
7 LYMPHATIC DRUG INSUFFICIENCY 245264 1% 100% 2 Search LYMPHATIC+DRUG+INSUFFICIENCY Search LYMPHATIC+DRUG+INSUFFICIENCY
8 MAGNETOELECTRIC NANOPARTICLES 245264 1% 100% 2 Search MAGNETOELECTRIC+NANOPARTICLES Search MAGNETOELECTRIC+NANOPARTICLES
9 PROTEASE MACAQUE MODEL 245264 1% 100% 2 Search PROTEASE+MACAQUE+MODEL Search PROTEASE+MACAQUE+MODEL
10 HUMAN IMMUNODEFICIENCY VIRUS TYPE ONE 220735 1% 60% 3 Search HUMAN+IMMUNODEFICIENCY+VIRUS+TYPE+ONE Search HUMAN+IMMUNODEFICIENCY+VIRUS+TYPE+ONE

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 GIACALONE, G , HILLAIREAU, H , FATTAL, E , (2015) IMPROVING BIOAVAILABILITY AND BIODISTRIBUTION OF ANTI-HIV CHEMOTHERAPY.EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 75. ISSUE . P. 40 -53 38 31% 4
2 MARTINEZ-SKINNER, AL , ARAINGA, MA , PULIGUJJA, P , PALANDRI, DL , BALDRIDGE, HM , EDAGWA, BJ , MCMILLAN, JM , MOSLEY, RL , GENDELMAN, HE , (2015) CELLULAR RESPONSES AND TISSUE DEPOTS FOR NANOFORMULATED ANTIRETROVIRAL THERAPY.PLOS ONE. VOL. 10. ISSUE 12. P. - 25 44% 1
3 EDAGWA, BJ , ZHOU, T , MCMILLAN, JM , LIU, XM , GENDELMAN, HE , (2014) DEVELOPMENT OF HIV RESERVOIR TARGETED LONG ACTING NANOFORMULATED ANTIRETROVIRAL THERAPIES.CURRENT MEDICINAL CHEMISTRY. VOL. 21. ISSUE 36. P. 4186 -4198 36 29% 8
4 SHAO, JW , KRAFT, JC , LI, BW , YU, J , FREELING, J , KOEHN, J , HO, RJ , (2016) NANODRUG FORMULATIONS TO ENHANCE HIV DRUG EXPOSURE IN LYMPHOID TISSUES AND CELLS: CLINICAL SIGNIFICANCE AND POTENTIAL IMPACT ON TREATMENT AND ERADICATION OF HIV/AIDS.NANOMEDICINE. VOL. 11. ISSUE 5. P. 545 -564 28 34% 1
5 PARBOOSING, R , MAGUIRE, GEM , GOVENDER, P , KRUGER, HG , (2012) NANOTECHNOLOGY AND THE TREATMENT OF HIV INFECTION.VIRUSES-BASEL. VOL. 4. ISSUE 4. P. 488 -520 37 25% 24
6 DAS, MK , SARMA, A , CHAKRABORTY, T , (2016) NANO-ART AND NEUROAIDS.DRUG DELIVERY AND TRANSLATIONAL RESEARCH. VOL. 6. ISSUE 5. P. 452 -472 30 28% 1
7 KUMAR, L , VERMA, S , PRASAD, DN , BHARDWAJ, A , VAIDYA, B , JAIN, AK , (2015) NANOTECHNOLOGY: A MAGIC BULLET FOR HIV AIDS TREATMENT.ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. VOL. 43. ISSUE 2. P. 71 -86 29 30% 1
8 PULIGUJJA, P , BALKUNDI, SS , KENDRICK, LM , BALDRIDGE, HM , HILAIRE, JR , BADE, AN , DASH, PK , ZHANG, G , POLUEKTOVA, LY , GORANTLA, S , ET AL (2015) PHARMACODYNAMICS OF LONG-ACTING FOLIC ACID-RECEPTOR TARGETED RITONAVIR-BOOSTED ATAZANAVIR NANOFORMULATIONS.BIOMATERIALS. VOL. 41. ISSUE . P. 141 -150 16 44% 7
9 MEHENDALE, R , JOSHI, M , PATRAVALE, V , (2013) NANOMEDICINES FOR TREATMENT OF VIRAL DISEASES.CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS. VOL. 30. ISSUE 1. P. 1 -49 33 22% 8
10 NAIR, M , JAYANT, RD , KAUSHIK, A , SAGAR, V , (2016) GETTING INTO THE BRAIN: POTENTIAL OF NANOTECHNOLOGY IN THE MANAGEMENT OF NEUROAIDS.ADVANCED DRUG DELIVERY REVIEWS. VOL. 103. ISSUE . P. 202 -217 29 20% 2

Classes with closest relation at Level 1


Rank Class id link
1 26135 LYMPHATIC TARGETING//ACTIVATED CARBON PARTICLES//BIOMED ENGN CANC
2 6821 BLOOD BRAIN BARRIER//BRAIN TARGETING//SMART DRUG DELIVERY
3 13359 POLYALKYLCYANOACRYLATE//POLYBUTYLCYANOACRYLATE//POLYETHYLCYANOACRYLATE
4 11702 I TECH SERV//LAMIVUDINE//EMTRICITABINE
5 26335 VIRAL BURDEN//AIDS INFECT PARASIT DIS PATHOL//BERNHARD NOCHT INSTITUTE
6 17014 CARRIER ERYTHROCYTES//HYPOTONIC DIALYSIS//NANOERYTHROSOMES
7 6181 ATAZANAVIR//RITONAVIR//LOPINAVIR
8 29007 MICELLE FORMING POLYMER//N 2 HYDROXY 3 TRIMETHYLAMMONIUM PROPYL CHITOSAN CHLORIDE HTCC//INFECT DIS ANIM MODELS GRP
9 3809 SOLID LIPID NANOPARTICLES//NANOSTRUCTURED LIPID CARRIERS//LIPID NANOPARTICLES
10 3989 MICROBICIDE//SPERMICIDE//NONOXYNOL 9

Go to start page